Screener
ADMA Biologics ADMA Plasma Collection Centers — Cost Of Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
| (in thousands) | ADMA Bio Manufacturing | Plasma Collection Centers | Total |
|---|---|---|---|
| Revenues | $$123,637 | $723 | 124,360 |
| Cost of product revenue | 37,564 | 554 | 38,118 |
| Research and development | 6,014 | - | 6,014 |
| Plasma center operating expenses | - | 1,026 | 1,026 |
| Gain on sale of plasma centers | - | - | - |
| Selling, marketing and distribution | 7,634 | - | 7,634 |
| Depreciation and amortization expense | 1,281 | 499 | 1,780 |
| General and administrative expense | 8,340 | - | 8,340 |
Item 1. Financial Statements.
FAQ
- What is ADMA Biologics's plasma collection centers — cost of revenue?
- ADMA Biologics (ADMA) reported plasma collection centers — cost of revenue of $554K in Q2 2026.
- What is the long-term trend for ADMA Biologics's plasma collection centers — cost of revenue?
- Over 3 years (2022 to 2025), ADMA Biologics's plasma collection centers — cost of revenue has grown at a 20.9% compound annual growth rate (CAGR), from $9.93M to $17.55M.
- What does plasma collection centers — cost of revenue mean?
- Includes the direct costs associated with operating plasma collection centers, such as donor compensation, center staffing, and supplies. This metric is critical for assessing the direct production efficiency of the plasma supply chain. Monitoring this helps determine the segment's ability to manage variable costs relative to plasma volume.
Ask your AI about ADMA Biologics's plasma collection centers — cost of revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude